Outsourcing Formulation Services for Biologics.
In: Pharmaceutical Technology, Jg. 47 (2023-09-01), Heft 9, S. 46-48
Online
serialPeriodical
Zugriff:
The article discusses the increased investment in therapies to treat respiratory diseases, particularly severe acute respiratory syndrome coronavirus (SARS-CoV-2), driven by the COVID-19 pandemic. It emphasizes the importance of selecting the right outsourcing partner with expertise, infrastructure, and regulatory knowledge to ensure the success of formulation development projects.
Titel: |
Outsourcing Formulation Services for Biologics.
|
---|---|
Autor/in / Beteiligte Person: | Thomas, Felicity |
Link: | |
Zeitschrift: | Pharmaceutical Technology, Jg. 47 (2023-09-01), Heft 9, S. 46-48 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 1543-2521 (print) |
Schlagwort: |
|
Sonstiges: |
|